PHAT - שולי רווח נקי Phathom Pharmaceuticals

סמל מסחרי של phathompharma.com (PHAT)

Phathom Pharmaceuticals (PHAT) relies on robotic packaging for gastrointestinal treatments and premium pricing for innovative drugs. Organic sales growth without mergers serves as the primary driver, which is confirmed by the net margin structure on the GURU.Markets terminal chart. The value of -30.20 describes the current status of the metric, allowing investors to accurately assess the profit percentage of every dollar of revenue.

רווחיות מכירות לפי רווח נקי phathompharma.com (PHAT): לתקופה 04.07.2022 - 19.11.2026

פילוחים אנליטיים של חברת Phathom Corp (PHAT)

אנליטיקה מסכמת של החברה:phathompharma.com - PHAT
מוצר המיוצר על ידי Phathom Pharma

The fabless model of Phathom Pharmaceuticals (PHAT), based on outsourced production, is directly reflected in the dynamics of the net profit margin. This indicator determines the share of final profit in every dollar of revenue, allowing investors to assess the efficiency of operating expense control and the risk of investing in undervalued but low-margin assets.